A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia

A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease

NCT01052779 ·Status: COMPLETED ·Phase: PHASE2

A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

NCT01264679 ·Status: TERMINATED ·Phase: PHASE3

A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease

NCT01155375 ·Status: TERMINATED ·Phase: PHASE3

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

NCT00223977 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease

NCT02968368 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)

NCT03619850 ·Status: RECRUITING ·Phase: PHASE3

A Single Ascending Study of IOP Injection in Patients With Iron Deficient Anemia

NCT03485053 ·Status: TERMINATED ·Phase: PHASE2

Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)

NCT00994318 ·Status: COMPLETED ·Phase: PHASE3

Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia

NCT06080555 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

NCT01280240 ·Status: COMPLETED ·Phase: PHASE1

Iron Indices and Intravenous Ferumoxytol: Time to Steady State

NCT01148745 ·Status: COMPLETED ·Phase: PHASE4

Dose-escalation Trial of the Safety, Pharmacokinetics, and Pharmacodynamics of Iron Isomaltoside (Monofer®)

NCT03013439 ·Status: COMPLETED ·Phase: PHASE1

Iron Isomaltoside for the Treatment of Anemia in Peritoneal Dialysis Patients

NCT06830941 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients

NCT00223964 ·Status: COMPLETED ·Phase: PHASE4

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients Receiving Erythropoietic Agents

NCT00224042 ·Status: COMPLETED ·Phase: PHASE4

Study to Test the Hypothesis of Non-inferior Efficacy and Safety of Ferrum Lek® (Iron (III) Hydroxide Polymaltosate), 100 mg Chewable Tablets (Lek d.d., Slovenia), as Compared With MALTOFER® (Vifor S.A., Switzerland), in Subjects With Mild and Moderate Iron Deficiency Anemia.

NCT03993288 ·Status: COMPLETED ·Phase: PHASE3

PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

NCT04543812 ·Status: COMPLETED ·Phase: PHASE3

A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

NCT03399084 ·Status: COMPLETED ·Phase: PHASE1

Can Iron Lessen Anemia Due to Cancer and Chemotherapy: A Study to Investigate the Efficacy and Safety of Injectafer®

NCT02453334 ·Status: COMPLETED ·Phase: PHASE3

ASP1517 Phase 2 Clinical Trial - Double-Blind Study of ASP1517 for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis-

NCT01964196 ·Status: COMPLETED ·Phase: PHASE2

Effect of Ferrlecit® Versus Oral Iron on Iron Deficient Chronic Kidney Disease (CKD) Patients

NCT00224055 ·Status: COMPLETED ·Phase: PHASE4

Comparison Between Effects of Two Iron Preparations on Protein in the Urine

NCT00534144 ·Status: COMPLETED ·Phase: PHASE1

Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

NCT00631163 ·Status: COMPLETED ·Phase: PHASE2

Adjuvant I.V. Iron Therapy During Erythropoetin Treatment of Anemic Patients With Lymphoproliferative Disorders.

NCT00145652 ·Status: COMPLETED ·Phase: PHASE3

Treatment Response of Injectafer vs Oral Iron to Baseline Hepcidin Levels in Patients With Iron Deficiency Anemia (IDA) Secondary to Inflammatory Bowel Disease (IBD) or Gastric Bypass

NCT02086968 ·Status: COMPLETED ·Phase: PHASE4